Health Care • Hospital/Nursing Management
$473.19 ▼ -4.89
(-1.02%)
MKT CAP: $98.85B • VOL: 1.12M
52W L $354 52W H $557
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$397
MEDIAN
$530
MEAN
$539
HIGH
$644
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE HCA TAPE
HCA // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $572.56 | $544.17 | 2025-02-14 | $430.60 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $596.22 | $558.36 | 2025-02-06 | $444.80 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $539.44 | $520.51 | 2025-01-29 | $454.26 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $482.65 | — | 2025-01-17 | $463.73 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $416.41 | $449.53 | 2025-01-09 | $421.14 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $563.10 | $492.12 | 2024-12-18 | $411.68 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $458.99 | $477.92 | 2024-12-04 | $440.07 | -4.3% | 48% | C |